Medicare Enrolled
Dr. Abdallah Dlewati, M.D.
Endocrinology · Flint, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dlewati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dlewati?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dlewati
Dr. Abdallah Dlewati is an endocrinology specialist in Flint, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dlewati performed 2,872 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dlewati received a total of $8,998 from 69 pharmaceutical and/or device companies across 512 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dlewati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 9% volume in MI
$8,998 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,872
Medicare services
Top 9% in MI for endocrinology
Not available
Unique patients (not deduplicated)
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
860 | $96 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
781 | $65 | $112 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
452 | $42 | $70 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
312 | $3 | $5 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
211 | $108 | $200 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
151 | $28 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $124 | $285 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $135 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,998
Total received (2018-2024)
Avg $1,285/year across 7 years
Top 23% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
512
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,490
2023
$1,455
2022
$1,460
2021
$1,614
2020
$846
2019
$1,248
2018
$886
Payments by company (2024)
Lilly USA, LLC
$234
Novo Nordisk Inc
$119
Amgen Inc.
$118
SANOFI-AVENTIS U.S. LLC
$90
Abbott Laboratories
$79
Astellas Pharma US Inc
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
ABBVIE INC.
$70
Antares Pharma, Inc.
$46
Alexion Pharmaceuticals, Inc.
$46
Corcept Therapeutics
$44
Esperion Therapeutics, Inc.
$43
Radius Health, Inc.
$43
Alvogen Inc
$39
Insulet Corporation
$38
PFIZER INC.
$36
BETA BIONICS, INC.
$28
EVOKE PHARMA, INC.
$23
Bayer Healthcare Pharmaceuticals Inc.
$23
Ascensia Diabetes Care Us Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
Amneal Pharmaceuticals LLC
$21
Xeris Pharmaceuticals, Inc.
$21
Verity Pharmaceuticals Inc.
$20
Kyowa Kirin, Inc.
$20
Dexcom, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$19
Acella Pharmaceuticals, LLC
$17
CeQur Corporation
$16
Medtronic, Inc.
$16
TheracosBio, LLC
$11
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$887
Lilly USA, LLC
$752
Abbott Laboratories
$612
SANOFI-AVENTIS U.S. LLC
$531
Corcept Therapeutics
$449
Amgen Inc.
$392
Radius Health, Inc.
$324
Boehringer Ingelheim Pharmaceuticals, Inc.
$310
Merck Sharp & Dohme Corporation
$286
Antares Pharma, Inc.
$258
Xeris Pharmaceuticals, Inc.
$257
Amarin Pharma Inc.
$219
Dexcom, Inc.
$195
Amneal Pharmaceuticals LLC
$174
Medtronic, Inc.
$167
Insulet Corporation
$165
Supernus Pharmaceuticals, Inc.
$165
AstraZeneca Pharmaceuticals LP
$160
Alexion Pharmaceuticals, Inc.
$136
Ipsen Biopharmaceuticals, Inc
$134
Esperion Therapeutics, Inc.
$133
Medtronic MiniMed, Inc.
$124
AbbVie Inc.
$117
LifeScan, Inc.
$99
ABBVIE INC.
$92
Becton, Dickinson and Company
$92
PFIZER INC.
$82
IBSA Pharma Inc.
$82
Horizon Therapeutics plc
$81
Alvogen Inc
$79
LIFESCAN, INC.
$78
Astellas Pharma US Inc
$78
AbbVie, Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$69
Janssen Pharmaceuticals, Inc
$58
Bayer HealthCare Pharmaceuticals Inc.
$57
Amryt Pharma Holdings Ltd
$52
CeQur Corporation
$47
Embecta Corp.
$47
Clarus Therapeutics Inc.
$46
Merck Sharp & Dohme LLC
$44
Currax Pharmaceuticals LLC
$44
RECORDATI_RARE_DISEASES_INC.
$43
Zealand Pharma US, Inc.
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
EVOKE PHARMA, INC.
$40
Kyowa Kirin, Inc.
$39
MannKind Corporation
$37
Nevro Corp.
$36
Acerus Pharmaceuticals Corporation
$35
Ferring Pharmaceuticals Inc.
$35
Evoke Pharma, Inc.
$34
Kowa Pharmaceuticals America, Inc.
$34
Shire North American Group Inc
$31
Aytu BioScience, Inc
$30
Companion Medical, Inc.
$28
BETA BIONICS, INC.
$28
Gilead Sciences, Inc.
$27
Valeritas, Inc.
$24
Ascensia Diabetes Care Us Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
Verity Pharmaceuticals Inc.
$20
Ultragenyx Pharmaceutical Inc.
$18
Acella Pharmaceuticals, LLC
$17
Orexigen Therapeutics, Inc.
$17
Nalpropion Pharmaceuticals LLC
$15
Tolmar, Inc.
$13
Takeda Pharmaceuticals U.S.A., Inc.
$12
TheracosBio, LLC
$11
Top 3 companies account for 25.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · Brenzavvy · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GIMOTI · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · Norditropin · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
6
County median income
$60,673
Nearest hospital to ZIP centroid (approximate)
MCLAREN FLINT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dlewati is a clinical cardiology specialist, with above-average Medicare volume (top 9% in MI), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dlewati experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dlewati performed 860 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dlewati receive payments from pharmaceutical companies?
Yes. Dr. Dlewati received a total of $8,998 from 69 companies across 512 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dlewati's costs compare to other endocrinologists in Flint?
Dr. Dlewati's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dlewati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Flint
Browse endocrinologists in Flint ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology